Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-273141
Filing Date
2017-08-30
Accepted
2017-08-30 15:55:07
Documents
7
Period of Report
2017-10-05
Effectiveness Date
2017-08-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d433515ddef14a.htm DEF 14A 456980
2 GRAPHIC g433515dsp2.jpg GRAPHIC 49546
3 GRAPHIC g433515dsp3.jpg GRAPHIC 66360
4 GRAPHIC g433515g51o28.jpg GRAPHIC 6750
5 GRAPHIC g433515g68d40.jpg GRAPHIC 7348
6 GRAPHIC g433515g82l95.jpg GRAPHIC 13033
7 GRAPHIC g433515new.jpg GRAPHIC 51156
  Complete submission text file 0001193125-17-273141.txt   725808
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-17988 | Film No.: 171060635
SIC: 2835 In Vitro & In Vivo Diagnostic Substances